miR-409-3p is known to target ZEB1 [48–50], a major negative regulator of EBV lytic reactivation and infection [31,32,51], and TargetScan predicts that miR-381-3p may also target ZEB1 [52]). This evidence concerns the gene ZEB1 and infection.